FZD10-Gα13 signalling axis points to a role of FZD10 in CNS angiogenesis

Cellular Signalling

Volumn 32, Issue , 2017, Pages 93-103

  Hot, Belma ^a   Valnohova, Jana ^a   Arthofer, Elisa ^a,b   Simon, Katharina ^c   Shin, Jaekyung ^a   Uhlén, Mathias ^d   Kostenis, Evi ^c   Mulder, Jan ^a   Schulte, Gunnar ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^e MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Angiogenesis; Endothelial cell; FZD; GNA13; GPCR; WNT; YAP TAZ

Indexed keywords

BETA CATENIN; DISHEVELLED PROTEIN; FRIZZLED 10 PROTEIN; FRIZZLED PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; UNCLASSIFIED DRUG; WNT PROTEIN; FZD10 PROTEIN, HUMAN; FZD10 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; FZD10 GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR ENDOTHELIAL CELL; ANGIOGENESIS; ANIMAL; C57BL MOUSE; CELL LINE; CENTRAL NERVOUS SYSTEM; DRUG EFFECTS; METABOLISM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CELL LINE; CENTRAL NERVOUS SYSTEM; DISHEVELLED PROTEINS; ENDOTHELIUM, VASCULAR; FEMALE; FRIZZLED RECEPTORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HUMANS; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 85010799974     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2017.01.023     Document Type: Article

References (73)

1. [1] Schulte, G., International union of basic and clinical pharmacology. LXXX. The class Frizzled receptors. Pharmacol. Rev. 62:4 (2010), 632–667.
2. [2] Foord, S.M., Bonner, T.I., Neubig, R.R., Rosser, E.M., Pin, J.P., Davenport, A.P., Spedding, M., Harmar, A.J., International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev. 57:2 (2005), 279–288.
3. [3] Dijksterhuis, J.P., Petersen, J., Schulte, G., WNT/Frizzled signaling: receptor-ligand selectivity with focus on FZD-G protein signaling and its physiological relevance. Br. J. Pharmacol., 2013.
4. [4] Koike, J., Takagi, A., Miwa, T., Hirai, M., Terada, M., Katoh, M., Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochem. Biophys. Res. Commun. 262:1 (1999), 39–43.
5. [5] Nasevicius, A., Hyatt, T.M., Hermanson, S.B., Ekker, S.C., Sequence, expression, and location of zebrafish frizzled 10. Mech. Dev. 92:2 (2000), 311–314.
6. [6] Kemp, C.R., Willems, E., Wawrzak, D., Hendrickx, M., Agbor Agbor, T., Leyns, L., Expression of Frizzled5, Frizzled7, and Frizzled10 during early mouse development and interactions with canonical Wnt signaling. Dev. Dyn. 236:7 (2007), 2011–2019.
7. [7] Nunnally, A.P., Parr, B.A., Analysis of Fz10 expression in mouse embryos. Dev. Genes Evol. 214:3 (2004), 144–148.
8. [8] Yan, Y., Li, Y., Hu, C., Gu, X., Liu, J., Hu, Y.A., Yang, Y., Wei, Y., Zhao, C., Expression of Frizzled10 in mouse central nervous system. Gene Expr. Patterns 9:3 (2009), 173–177.
9. [9] Terasaki, H., Saitoh, T., Shiokawa, K., Katoh, M., Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway. Int. J. Mol. Med. 9:2 (2002), 107–112.
10. [10] Fukukawa, C., Nagayama, S., Tsunoda, T., Toguchida, J., Nakamura, Y., Katagiri, T., Activation of the non-canonical Dvl-Rac1-JNK pathway by Frizzled homologue 10 in human synovial sarcoma. Oncogene 28:8 (2009), 1110–1120.
11. [11] Fukukawa, C., Hanaoka, H., Nagayama, S., Tsunoda, T., Toguchida, J., Endo, K., Nakamura, Y., Katagiri, T., Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci. 99:2 (2008), 432–440.
12. [12] Nagayama, S., Fukukawa, C., Katagiri, T., Okamoto, T., Aoyama, T., Oyaizu, N., Imamura, M., Toguchida, J., Nakamura, Y., Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene 24:41 (2005), 6201–6212.
13. [13] Wang, Z.S., Shu, W.G., Lu, M.M., Morrisey, E.E., Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol. Cell. Biol. 25:12 (2005), 5022–5030.
14. [14] Parr, B.A., Shea, M.J., Vassileva, G., McMahon, A.P., Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 119:1 (1993), 247–261.
15. [15] Ahumada, A., Slusarski, D.C., Liu, X.X., Moon, R.T., Malbon, C.C., Wang, H.Y., Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science 298:5600 (2002), 2006–2010.
16. [16] Liu, T., Liu, X., Wang, H., Moon, R.T., Malbon, C.C., Activation of rat frizzled-1 promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via pathways that require Galpha(q) and Galpha(o) function. J. Biol. Chem. 274:47 (1999), 33539–33544.
17. [17] Sheldahl, L.C., Park, M., Malbon, C.C., Moon, R.T., Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr. Biol. 9:13 (1999), 695–698.
18. [18] Liu, X., Liu, T., Slusarski, D.C., Yang-Snyder, J., Malbon, C.C., Moon, R.T., Wang, H., Activation of a frizzled-2/beta-adrenergic receptor chimera promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via Galphao and Galphat. Proc. Natl. Acad. Sci. U. S. A. 96:25 (1999), 14383–14388.
19. [19] Slusarski, D.C., Corces, V.G., Moon, R.T., Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390:6658 (1997), 410–413.
20. [20] Katanaev, V.L., Buestorf, S., Frizzled Proteins are Bona Fide G Protein-coupled Receptors. (Nature Precedings hdl:10101/npre.2009.2765.1, 2009.
21. [21] Katanaev, V.L., Ponzielli, R., Semeriva, M., Tomlinson, A., Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120:1 (2005), 111–122.
22. [22] Kilander, M.B., Petersen, J., Andressen, K.W., Ganji, R.S., Levy, F.O., Schuster, J., Dahl, N., Bryja, V., Schulte, G., Disheveled regulates precoupling of heterotrimeric G proteins to Frizzled 6. FASEB J., 2014.
23. [23] Kilander, M.B., Dahlstrom, J., Schulte, G., Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity. Cell. Signal. 26:9 (2014), 1943–1949.
24. [24] Halleskog, C., Dijksterhuis, J.P., Kilander, M.B., Becerril-Ortega, J., Villaescusa, J.C., Lindgren, E., Arenas, E., Schulte, G., Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J. Neuroinflammation, 9(1), 2012, 111.
25. [25] Kilander, M.B.C., Dijksterhuis, J.P., Ganji, R.S., Bryja, V., Schulte, G., WNT-5A stimulates the GDP/GTP exchange at pertussis toxin-sensitive heterotrimeric G proteins. Cell. Signal. 23:3 (2011), 550–554.
26. [26] Kilander, M.B.C., Halleskog, C., Schulte, G., Purified WNTs differentially activate beta-catenin-dependent and -independent pathways in mouse microglia-like cells. Acta Physiol. 203:3 (2011), 363–372.
27. [27] Ramirez, V.T., Ramos-Fernandez, E., Henriquez, J.P., Lorenzo, A., Inestrosa, N.C., Wnt-5a/Frizzled9 receptor signaling through the Galphao/Gbetagamma complex regulates dendritic spine formation. J. Biol. Chem., 2016.
28. [28] Arthofer, E., Hot, B., Petersen, J., Strakova, K., Jager, S., Grundmann, M., Kostenis, E., Gutkind, S.J., Schulte, G., WNT stimulation dissociates a Frizzled 4 inactive state complex with Galpha12/13. Mol. Pharmacol., 2016.
29. [29] Robitaille, J., MacDonald, M.L., Kaykas, A., Sheldahl, L.C., Zeisler, J., Dube, M.P., Zhang, L.H., Singaraja, R.R., Guernsey, D.L., Zheng, B., Siebert, L.F., Hoskin-Mott, A., Trese, M.T., Pimstone, S.N., Shastry, B.S., Moon, R.T., Hayden, M.R., Goldberg, Y.P., Samuels, M.E., Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 32:2 (2002), 326–330.
30. [30] Schulte, G., Frizzleds and WNT/beta-catenin signaling - the black box of ligand-receptor selectivity, complex stoichiometry and activation kinetics. Eur. J. Pharmacol., 2015.
31. [31] van Amerongen, R., Mikels, A., Nusse, R., Alternative wnt signaling is initiated by distinct receptors. Sci. Signal., 1(35), 2008 (re9).
32. [32] Halleskog, C., Schulte, G., Pertussis toxin-sensitive heterotrimeric G(alphai/o) proteins mediate WNT/beta-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A. Cell. Signal. 25:4 (2013), 822–828.
33. [33] Stenman, J.M., Rajagopal, J., Carroll, T.J., Ishibashi, M., McMahon, J., McMahon, A.P., Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322:5905 (2008), 1247–1250.
34. [34] Sivaraj, K.K., Takefuji, M., Schmidt, I., Adams, R.H., Offermanns, S., Wettschureck, N., G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev. Cell 25:4 (2013), 427–434.
35. [35] Offermanns, S., Mancino, V., Revel, J.P., Simon, M.I., Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275:5299 (1997), 533–536.
36. [36] Ruppel, K.M., Willison, D., Kataoka, H., Wang, A., Zheng, Y.W., Cornelissen, I., Yin, L., Xu, S.M., Coughlin, S.R., Essential role for Galpha13 in endothelial cells during embryonic development. Proc. Natl. Acad. Sci. U. S. A. 102:23 (2005), 8281–8286.
37. [37] Liu, G., Han, J., Profirovic, J., Strekalova, E., Voyno-Yasenetskaya, T.A., Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. Angiogenesis 12:1 (2009), 1–15.
38. [38] Cervenka, I., Valnohova, J., Bernatik, O., Harnos, J., Radsetoulal, M., Sedova, K., Hanakova, K., Potesil, D., Sedlackova, M., Salasova, A., Steinhart, Z., Angers, S., Schulte, G., Hampl, A., Zdrahal, Z., Bryja, V., Dishevelled is a NEK2 kinase substrate controlling dynamics of centrosomal linker proteins. Proc. Natl. Acad. Sci. U. S. A. 113:33 (2016), 9304–9309.
39. [39] Gammons, M.V., Rutherford, T.J., Steinhart, Z., Angers, S., Bienz, M., Essential role of the dishevelled DEP domain in a Wnt-dependent human-cell-based complementation assay. J. Cell Sci. 129:20 (2016), 3892–3902.
40. [40] Halleskog, C., Mulder, J., Dahlström, J., Mackie, K., Hortobágyi, T., Tanila, H., Kumar Puli, L., Färber, K., Harkany, T., Schulte, G., WNT signaling in activated microglia is pro-inflammatory. Glia 59:1 (2011), 119–131.
41. [41] Schroder, R., Schmidt, J., Blattermann, S., Peters, L., Janssen, N., Grundmann, M., Seemann, W., Kaufel, D., Merten, N., Drewke, C., Gomeza, J., Milligan, G., Mohr, K., Kostenis, E., Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells. Nat. Protoc. 6:11 (2011), 1748–1760.
42. [42] Proffitt, K.D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M.A., Hannoush, R.N., Virshup, D.M., Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res. 73:2 (2013), 502–507.
43. [43] Aznar, N., Midde, K.K., Dunkel, Y., Lopez-Sanchez, I., Pavlova, Y., Marivin, A., Barbazan, J., Murray, F., Nitsche, U., Janssen, K.P., Willert, K., Goel, A., Abal, M., Garcia-Marcos, M., Ghosh, P., Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. eLife, 4, 2015, e07091.
44. [44] Koval, A., Katanaev, V.L., Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins. Biochem. J. 433:3 (2011), 435–440.
45. [45] Qin, K., Dong, C., Wu, G., Lambert, N.A., Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers. Nat. Chem. Biol. 7:10 (2011), 740–747.
46. [46] Gao, C., Chen, Y.G., Dishevelled: the hub of wnt signaling. Cell. Signal. 22:5 (2010), 717–727.
47. [47] Bryja, V., Schulte, G., Rawal, N., Grahn, A., Arenas, E., Wnt-5a induces dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J. Cell Sci. 120:Pt 4 (2007), 586–595.
48. [48] Bryja, V., Gradl, D., Schambony, A., Arenas, E., Schulte, G., beta-Arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 104:16 (2007), 6690–6695.
49. [49] Grundmann, M., Kostenis, E., Label-free biosensor assays in GPCR screening. Methods Mol. Biol. 1272 (2015), 199–213.
50. [50] Rossman, K.L., Der, C.J., Sondek, J., GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6:2 (2005), 167–180.
51. [51] Park, H.W., Kim, Y.C., Yu, B., Moroishi, T., Mo, J.S., Plouffe, S.W., Meng, Z., Lin, K.C., Yu, F.X., Alexander, C.M., Wang, C.Y., Guan, K.L., Alternative Wnt signaling activates YAP/TAZ. Cell 162:4 (2015), 780–794.
52. [52] Yu, F.X., Zhao, B., Panupinthu, N., Jewell, J.L., Lian, I., Wang, L.H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X.D., Mills, G.B., Guan, K.L., Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150:4 (2012), 780–791.
53. [53] Choi, H.J., Kwon, Y.G., Roles of YAP in mediating endothelial cell junctional stability and vascular remodeling. BMB Rep. 48:8 (2015), 429–430.
54. [54] Piccolo, S., Dupont, S., Cordenonsi, M., The biology of YAP/TAZ: hippo signaling and beyond. Physiol. Rev. 94:4 (2014), 1287–1312.
55. [55] Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., Fassina, A., Cordenonsi, M., Piccolo, S., YAP/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response. Cell 158:1 (2014), 157–170.
56. [56] Feng, X., Chen, Q., Gutkind, J.S., Oncotargeting G proteins: the hippo in the room. Oncotarget 5:22 (2014), 10997–10999.
57. [57] Choi, H.J., Zhang, H., Park, H., Choi, K.S., Lee, H.W., Agrawal, V., Kim, Y.M., Kwon, Y.G., Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat. Commun., 6, 2015, 6943.
58. [58] Kozasa, T., Jiang, X., Hart, M.J., Sternweis, P.M., Singer, W.D., Gilman, A.G., Bollag, G., Sternweis, P.C., p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280:5372 (1998), 2109–2111.
59. [59] Hupe, M., Li, M.X., Gertow Gillner, K., Adams, R.H., Stenman, J.M., Evaluation of TRAP-sequencing technology with a versatile conditional mouse model. Nucleic Acids Res., 42(2), 2014, e14.
60. [60] Tata, M., Ruhrberg, C., Fantin, A., Vascularisation of the central nervous system. Mech. Dev. 138:Pt 1 (2015), 26–36.
61. [61] Uhlen, M., Fagerberg, L., Hallstrom, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, A., Kampf, C., Sjostedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg, E., Navani, S., Szigyarto, C.A., Odeberg, J., Djureinovic, D., Takanen, J.O., Hober, S., Alm, T., Edqvist, P.H., Berling, H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk, J.M., Hamsten, M., von Feilitzen, K., Forsberg, M., Persson, L., Johansson, F., Zwahlen, M., von Heijne, G., Nielsen, J., Ponten, F., Proteomics. Tissue-based map of the human proteome. Science, 347(6220), 2015, 1260419.
62. [62] Whorton, M.R., Bokoch, M.P., Rasmussen, S.G., Huang, B., Zare, R.N., Kobilka, B., Sunahara, R.K., A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U. S. A. 104:18 (2007), 7682–7687.
63. [63] Carmon, K.S., Loose, D.S., Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol. Cancer Res. 6:6 (2008), 1017–1028.
64. [64] Milligan, G., Principles: extending the utility of [35S]GTP gamma S binding assays. Trends Pharmacol. Sci. 24:2 (2003), 87–90.
65. [65] Malbon, C.C., Wnt signalling: the case of the 'missing' G-protein (vol 433, pg e3, 2011). Biochem. J., 434(3), 2011, 575.
66. [66] Schulte, G., Bryja, V., The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol. Sci. 28:10 (2007), 518–525.
67. [67] Atwood, B.K., Lopez, J., Wager-Miller, J., Mackie, K., Straiker, A., Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics, 12, 2011, 14.
68. [68] Ueno, K., Hiura, M., Suehiro, Y., Hazama, S., Hirata, H., Oka, M., Imai, K., Dahiya, R., Hinoda, Y., Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia 10:7 (2008), 697–705.
69. [69] Xu, Q., Wang, Y., Dabdoub, A., Smallwood, P.M., Williams, J., Woods, C., Kelley, M.W., Jiang, L., Tasman, W., Zhang, K., Nathans, J., Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116:6 (2004), 883–895.
70. [70] Worzfeld, T., Wettschureck, N., Offermanns, S., G(12)/G(13)-mediated signalling in mammalian physiology and disease. Trends Pharmacol. Sci. 29:11 (2008), 582–589.
71. [71] Griffin, C.T., Srinivasan, Y., Zheng, Y.W., Huang, W., Coughlin, S.R., A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293:5535 (2001), 1666–1670.
72. [72] Allende, M.L., Yamashita, T., Proia, R.L., G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102:10 (2003), 3665–3667.
73. [73] Marti, P., Stein, C., Blumer, T., Abraham, Y., Dill, M.T., Pikiolek, M., Orsini, V., Jurisic, G., Megel, P., Makowska, Z., Agarinis, C., Tornillo, L., Bouwmeester, T., Ruffner, H., Bauer, A., Parker, C.N., Schmelzle, T., Terracciano, L.M., Heim, M.H., Tchorz, J.S., YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors. Hepatology 62:5 (2015), 1497–1510.